Agentix Corp.
- Close
- Oct 22, 2026 · +0.00%
- Market cap
- $1.60M
- 40.07M shares
- Filings
- 154
FY 2023−100.0% FY23 yoy
Q2 2027N/M FY26 yoy
Q2 2027N/M FY26 yoy
FY 2014derived
—Q2 2027N/M FY26 yoy
Q2 2027−82.8% FY26 yoy
- $1.60M
- —
- —
- —
- —
- —
FY2026 figures · derived
Price
Oct 22, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-03-31 | $0 | reported | |
| FY 2022 | 2022-03-31 | $1,240 | reported | |
| FY 2021 | 2021-08-31 | $1,240 | reported | |
| FY 2017 | 2017-08-31 | $2,250 | reported | |
| FY 2016 | 2016-08-31 | $43,143 | reported | |
| FY 2015 | 2015-08-31 | $28,375 | reported |
Biological products, except diagnostic substances
Agentix Corp. is the 167th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
PMCBPharmaCyte Biotech, Inc.$0.0——$3.3MVIVSVivoSim Labs, INC.$131.0K9.0%10,567.2%$2.8MABPOAbpro Holdings, Inc.———$2.5MCLDICalidi Biotherapeutics, Inc.———$2.3MBCABBioAtla, Inc.———$2.1MSLXNSilexion Therapeutics Corp———$1.7M
AGTXAgentix Corp. (this company)———$1.6M
SCNIScinai Immunotherapeutics Ltd.$1.3M99.2%633.6%$1.6MCEROCero Therapeutics Holdings, Inc.———$716.3KPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Agentix Corp. · CIK 1603345 · Engraved from SEC EDGAR